Healthy Volunteer Study
62
10
10
47
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 62 trials
97.9%
+11.4% vs benchmark
0%
0 trials in Phase 3/4
17%
8 of 47 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 47 completed trials
Clinical Trials (62)
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
The Role of NaV1.8 in Human Pain Models
Differential Learning Enhances Motor Performance and Retention in Sport Science Students
Muscle Vibration as a Countermeasure Against Hypoactivity-induced
Pain Induced by m-Cresol as Preservative
Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects
Near-InfraRed Spectroscopy of Auricular Stimulation
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response
A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers
Phase 1 BIO 300 Oral Suspension
Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects
Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin
Smart Blister Packaging and Mobile Application to Monitor and Support Medication Adherence: a Two-arm Usability Study
A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations